Dental Literature Watch · Trial · Periodontics
Probiotic Lozenges Add a Short-Term Gain After Non-Surgical Perio Therapy
TL;DR
- Lozenges containing Lacticaseibacillus rhamnosus PB01, Latilactobacillus curvatus EB10 and xylitol, taken for 12 weeks after non-surgical periodontal treatment.
- Bleeding on probing and the number of pockets ≥ 5 mm fell significantly more in the probiotic group (p < 0.05).
- The microbiome moved in the right direction: periodontitis-associated species associated with placebo, health-associated streptococci and neisseria with probiotic.
- Short-term. Twelve weeks, with no data beyond that.
- Both arms received proper non-surgical treatment first — this is an adjunct, never a substitute.
The study
| Design | Randomised, double-blinded, placebo-controlled trial |
| Population | 80 adults with stage II or III periodontitis; 61 completed (32 probiotic, 29 placebo) |
| Intervention | Non-surgical periodontal treatment at baseline, then 12 weeks of probiotic lozenges or placebo |
| Clinical result | Greater reduction in BoP% and in number of pockets ≥ 5 mm vs placebo (p < 0.05) |
| Microbiology | 16S sequencing subgingivally, metagenomics in saliva. Placebo associated with T. socranskii, S. sputigena, Dialister spp., F. nucleatum; probiotic with S. sanguinis, N. elongata, N. oralis |
💎 Insight — what this means chairside
The clinical outcomes are the ones patients feel
Bleeding on probing and residual deep pockets are what determine whether a patient goes to surgery or into maintenance.
Moving both in a 12-week window is a real, if modest, result.
Bleeding on probing and residual deep pockets are what determine whether a patient goes to surgery or into maintenance.
Moving both in a 12-week window is a real, if modest, result.
Strain specificity matters and gets ignored
This trial tested two named strains plus xylitol, not "probiotics" as a category.
A patient who buys a general probiotic from a supermarket is not taking what was studied here, and there is no reason to assume it behaves the same way.
This trial tested two named strains plus xylitol, not "probiotics" as a category.
A patient who buys a general probiotic from a supermarket is not taking what was studied here, and there is no reason to assume it behaves the same way.
The microbial shift is coherent with the clinical one
Away from Fusobacterium and Treponema, toward Streptococcus sanguinis and Neisseria.
That internal consistency is what makes a small trial more believable, even though it does not extend its duration.
Away from Fusobacterium and Treponema, toward Streptococcus sanguinis and Neisseria.
That internal consistency is what makes a small trial more believable, even though it does not extend its duration.
⚠️ The catch
Twelve weeks, and 19 of 80 did not complete
A quarter of the enrolled sample dropped out, and the follow-up ends exactly where periodontal maintenance begins.
Whether any of this persists at six or twelve months is unknown.
A quarter of the enrolled sample dropped out, and the follow-up ends exactly where periodontal maintenance begins.
Whether any of this persists at six or twelve months is unknown.
An adjunct to good treatment, not a shortcut around it
Every participant received non-surgical periodontal treatment.
The risk with a positive adjunct trial is that it becomes a product recommendation that quietly substitutes for debridement and oral hygiene.
Every participant received non-surgical periodontal treatment.
The risk with a positive adjunct trial is that it becomes a product recommendation that quietly substitutes for debridement and oral hygiene.
Cost falls entirely on the patient
Twelve weeks of a specific lozenge is an out-of-pocket expense for a modest short-term gain.
That is a fair conversation to have rather than a default recommendation.
Twelve weeks of a specific lozenge is an out-of-pocket expense for a modest short-term gain.
That is a fair conversation to have rather than a default recommendation.
⚡ Bottom line
- Stage II/III periodontitis after debridement → a 12-week probiotic course gave extra BoP and pocket reduction.
- Patient asks which probiotic → the trial used specific strains, not any product on a shelf.
- Considering it instead of maintenance → no. Every participant had proper treatment first.
- Expecting lasting benefit → unproven beyond 12 weeks.
🧪 Questions
Tap an answer — instant grade, deciding line, and the trap.
A 46-year-old with stage III periodontitis completed full-mouth non-surgical therapy six weeks ago. At review she has residual bleeding on probing and several 5 mm pockets. She has read about probiotics and asks whether taking one instead of returning for further debridement would work. What is the most accurate response based on the 2026 trial?
Deciding line: every participant received non-surgical periodontal treatment first and the probiotic was added on top, so the trial supports it only as an adjunct. Trap: the last option is the engineered trap because it is what patients actually do, while the trial tested two named strains with xylitol rather than probiotics as a category; saying there is no effect overcorrects and contradicts a genuinely positive short-term result.